ArticleACS omega2024
Facile Synthesis of a Pyrovanadate Ni
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Electrochemical performance of NiRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nickel pyrovanadate (NVO) and compositing rGO in different concentrations with NVO are synthesized via the solvothermal process. XRD patterns reveal the formation of crystalline NVO and amorphous rGO in the nanocomposite. The morphology of the material resembles the formation of an NVO hollow nanosphere through a template-free synthesis route with the effect of ethylene glycol. From the CV oxidation and reduction curve, the battery-type faradic reaction is observed. The specific surface area increment via the rGO concentration increment in nanocomposites is due to the partially encapsulated hollow sphere on the 2D active surface area of rGO owing to better specific capacitance and electrochemical stability. In addition, the maximum specific capacitance of 3807 F g
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.